Document Detail


Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice.
MedLine Citation:
PMID:  15169957     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The pathogenic mechanisms by which physical exercise influences atherosclerotic lesion formation remain poorly understood. Because vigorous physical training increases oxidative stress, this study tested the hypothesis that graduated and moderate physical exercise together with metabolic intervention (l-arginine and antioxidants) may contribute to increased vascular protection. Exercise training in mice was induced by graduated swimming. In hypercholesterolemic male mice on an atherogenic high-cholesterol diet, graduated and moderate exercise lowered plasma cholesterol and decreased atherosclerotic lesions compared with sedentary control mice. Antioxidants (1.0% vitamin E added to the chow and 0.05% vitamin C added to the drinking water) and l-arginine (6% in drinking water) supplementation to exercising hypercholesterolemic mice further and synergistically reduced atherosclerosis compared with untreated exercised mice. Arterial oxidation-specific epitopes and systemic oxidative stress were reduced by metabolic intervention. Graduated chronic exercise elicited an increase in production of nitric oxide through increased endothelial nitric oxide synthase expression and ameliorated scavenger activities. Thus, metabolic intervention with l-arginine and antioxidants together with graduated and moderate exercise training reduce atherosclerotic lesion formation.
Authors:
Claudio Napoli; Sharon Williams-Ignarro; Filomena De Nigris; Lilach O Lerman; Loredana Rossi; Carmen Guarino; Gelsomina Mansueto; Francesco Di Tuoro; Orlando Pignalosa; Gaetano De Rosa; Vincenzo Sica; Louis J Ignarro
Related Documents :
9351697 - Effects of exercise on the macrophage mhc ii response to inflammation.
23805167 - The role of exercise in facilitating basal ganglia function in parkinson's disease.
23518887 - A rare sign of ischemia during exercise ecg: pr interval lengthening in the recovery pe...
24157527 - Familial hypercholesterolemia impairs exercise-induced systemic vasodilation due to red...
2923057 - Paradoxical elevation of threshold to angina pectoris by cold pressor test in men with ...
22345427 - Modulation of autophagy and ubiquitin-proteasome pathways during ultra-endurance running.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.     Date:  2004-05-28
Journal Detail:
Title:  Proceedings of the National Academy of Sciences of the United States of America     Volume:  101     ISSN:  0027-8424     ISO Abbreviation:  Proc. Natl. Acad. Sci. U.S.A.     Publication Date:  2004 Jun 
Date Detail:
Created Date:  2004-06-09     Completed Date:  2004-08-17     Revised Date:  2013-04-18    
Medline Journal Info:
Nlm Unique ID:  7505876     Medline TA:  Proc Natl Acad Sci U S A     Country:  United States    
Other Details:
Languages:  eng     Pagination:  8797-802     Citation Subset:  IM    
Affiliation:
Department of General Pathology, Medicine, Clinical Pathology, and Human Pathology, University of Naples, 80131 Naples, Italy. claunap@tin.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antioxidants / therapeutic use*
Arginine / therapeutic use
Arteriosclerosis / etiology,  metabolism,  prevention & control*
Ascorbic Acid / therapeutic use
Diet, Atherogenic
Hyperlipoproteinemia Type II / complications*,  metabolism,  therapy*
Male
Mice
Mice, Knockout
Nitric Oxide Synthase / metabolism
Nitric Oxide Synthase Type II
Nitric Oxide Synthase Type III
Oxidative Stress
Physical Conditioning, Animal*
Receptors, LDL / deficiency,  genetics
Vitamin E / therapeutic use
Grant Support
ID/Acronym/Agency:
HL-58433/HL/NHLBI NIH HHS; HL-66999/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Antioxidants; 0/Receptors, LDL; 1406-18-4/Vitamin E; 50-81-7/Ascorbic Acid; 74-79-3/Arginine; EC 1.14.13.39/Nitric Oxide Synthase; EC 1.14.13.39/Nitric Oxide Synthase Type II; EC 1.14.13.39/Nitric Oxide Synthase Type III; EC 1.14.13.39/Nos2 protein, mouse; EC 1.14.13.39/Nos3 protein, mouse
Comments/Corrections
Erratum In:
Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18262

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Affinity transfer by CDR grafting on a nonimmunoglobulin scaffold.
Next Document:  Frizzled6 controls hair patterning in mice.